Black Bird Biotech, Inc.: 10-Q filed 2016-11-07
What Black Bird Biotech, Inc. reported in its quarterly report filed 2016-11-07 (fiscal Q3 2016): 9 published measures, 26 facts as tagged in accession 0001144204-16-131976.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2016-11-07
- Fiscal period
- fiscal Q3 2016
- Accession
- 0001144204-16-131976 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; a measure with a published history links to it, and the history shows the latest-filed value per period. All Black Bird Biotech, Inc. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-09-30 | 19,930 | USD | |
| At 2015-12-31 | 12,455 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-09-30 | 781,696 | USD | |
| At 2015-12-31 | 693,891 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-09-30 | -761,766 | USD | |
| At 2015-12-31 | -681,436 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-07-01 to 2016-09-30 | -27,503 | USD | 92 |
| 2016-01-01 to 2016-09-30 | -80,330 | USD | 274 |
| 2015-07-01 to 2015-09-30 | -23,675 | USD | 92 |
| 2015-01-01 to 2015-09-30 | -81,247 | USD | 273 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-09-30 | -8,336,683 | USD | |
| At 2015-12-31 | -8,256,353 | USD |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-07-01 to 2016-09-30 | -19,700 | USD | 92 |
| 2016-01-01 to 2016-09-30 | -57,814 | USD | 274 |
| 2015-07-01 to 2015-09-30 | -16,912 | USD | 92 |
| 2015-01-01 to 2015-09-30 | -61,679 | USD | 273 |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-07-01 to 2016-09-30 | 7,803 | USD | 92 |
| 2016-01-01 to 2016-09-30 | 22,516 | USD | 274 |
| 2015-07-01 to 2015-09-30 | 6,763 | USD | 92 |
| 2015-01-01 to 2015-09-30 | 19,568 | USD | 273 |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-07-01 to 2016-09-30 | 19,700 | USD | 92 |
| 2016-01-01 to 2016-09-30 | 57,814 | USD | 274 |
| 2015-07-01 to 2015-09-30 | 16,912 | USD | 92 |
| 2015-01-01 to 2015-09-30 | 61,679 | USD | 273 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-09-30 | 85,970,665 | shares | |
| At 2015-12-31 | 85,970,665 | shares |
Inspect the source
- Entity
- Black Bird Biotech, Inc. / CIK 0001409999
- Captured
- SEC response SHA-256
df936db10ff162447a769152b36bd1ddff9f21ac96d53dd4e87253b660581055
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001409999.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))